Pennant Group earnings were $26.7M for the trailing 12 months ending Sep 30, 2025, with 11.4% growth year over year. The latest PNTG earnings report on Sep 30, 2025 announced Q3 2025 earnings of $6.1M, down 14.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PNTG reported annual earnings of $22.6M, with 68.6% growth.
PNTG past earnings growth
How has PNTG's earnings growth performed historically?
On PNTG's earnings call on Invalid Date, Pennant Group (NASDAQ: PNTG) reported Q3 2025 earnings per share (EPS) of $0.18, up 10% year over year. Total PNTG earnings for the quarter were $6.08 million. In the same quarter last year, Pennant Group's earnings per share (EPS) was $0.20.
As of the last Pennant Group earnings report, Pennant Group is currently profitable. Pennant Group's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $26.70 million, a 26.24% increase year over year.
What was PNTG's earnings growth in the past year?
As of Pennant Group's earnings date in Invalid Date, Pennant Group's earnings has grown 11.43% year over year. This is 1.61 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 13.04%. PNTG earnings in the past year totalled $26.70 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.